Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Methods of treating upper tract urothelial carcinomas

A technology of epithelial and chemotherapeutic agents, which is applied in the direction of pharmaceutical formulations, drug devices, and other medical devices, and can solve problems such as difficulty penetrating the urothelial barrier

Pending Publication Date: 2019-08-23
WESTERN UNIV OF HEALTH SCI +1
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Intraluminal delivery into the upper urinary tract presents unique challenges given the aqueous environment of ureteral contents, expulsion peristalsis, and difficulty penetrating the urothelial barrier

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of treating upper tract urothelial carcinomas
  • Methods of treating upper tract urothelial carcinomas
  • Methods of treating upper tract urothelial carcinomas

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1. PLIP-003

[0040] Table 1

[0041]

Embodiment 2

[0042] Example 2. PLIP-006

[0043] Table 2

[0044]

Embodiment 3

[0045] Example 3. PLIP-021

[0046] table 3

[0047] Element quantity Paclitaxel 27.4mg DMPG 12.2mg DMPC 90.4mg Mannitol 50mg

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to methods for locally delivering a chemotherapeutic agent to an upper tract urothelial carcinoma (UTUC). The methods involve placing a balloon catheter that has a working channel and a balloon into the ureter / renal pelvis via retrograde or antegrade ureteral access; inflating the catheter balloon to temporarily obstruct the ureter; infusing (instilling) a liposomal formulation that includes a chemotherapeutic agent into the working channel of the catheter; and allowing the infused liposomal formulation to dwell in the ureter and / or renal pelvis for a time sufficient to allow at least a portion of the liposomal formulation to adhere to the urothelial wall. In the methods of the invention, at least a portion of the infused chemotherapeutic-agent formulation adheres tothe urothelial wall while it is instilled and dwells in the ureter and / or renal pelvis. The disclosed methods can be performed as an adjuvant therapy to other methods of treating UTUC, such as ureteroscopic ablation or resection of the tumor.

Description

technical field [0001] The present invention relates to methods for the local delivery of chemotherapeutic agents to upper tract urothelial carcinoma (UTUC). The method comprises local delivery of a liposomal formulation of a chemotherapeutic agent into the ureter and / or renal pelvis via retrograde or antegrade catheter access. Background technique [0002] Upper tract urothelial carcinoma (UTUC) is a relatively uncommon type of cancer, accounting for only 5% to 10% of all urothelial carcinomas. (Leow et al., 2014, Suriano et al., 2014, Roupret et al., 2015). The annual incidence of UTUC in Western countries is estimated to be approximately two cases per 100,000 inhabitants (or 6000 cases / year). (Roupret et al., 2015). UTUC is most prevalent in people aged 70-90 and is three times more common in men than in women. In 17% of cases, concurrent bladder cancer was present. Intravesical recurrence occurs in 22% to 47% of UTUC patients, compared with 2% to 6% in the contralat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/127A61M25/00A61P35/00
CPCA61P35/00A61K9/0019A61K9/127A61K9/146A61K9/1277A61K31/337A61K33/243A61K45/06A61K9/0034A61K47/10A61M25/10A61M2025/105A61M2025/1052A61M2210/1089
Inventor 古鲁·V·贝塔格里纳塔拉詹·文卡特桑迈克尔·G·欧芙兰
Owner WESTERN UNIV OF HEALTH SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products